Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 380, Issue 23, Pages 2246-2255Publisher
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMra1807054
Keywords
-
Categories
Funding
- Alkermes
Ask authors/readers for more resources
This review explains harm-reduction strategies for three groups of patients: those who have not received previous opioid therapy, those receiving long-term opioid therapy, and those with an opioid use disorder. It explains both risk assessment and the current approach to the use of medications for opioid use disorder.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available